Drug intelligence / Profile preview

AVEENO Dermexa

Development stage
Unknown
Lead developer
Aveeno
Administration
Topical
01

Overview

AVEENO Dermexa is a topical emollient cream formulated to moisturize, soothe, and protect very dry, itchy skin and skin prone to eczema. Its key active ingredients are a triple oat complex (colloidal oatmeal, oat oil, oat extract) and ceramides. The product works by strengthening the skin’s natural barrier function and helping restore its microbiome balance. Colloidal oatmeal acts as a skin protectant with anti-irritant and antioxidant properties; ceramides help maintain the integrity of the stratum corneum (outermost layer of the epidermis). The cream is fragrance-free, steroid-free, suitable for babies through adults—including those with sensitive or atopic-prone skin—and is clinically proven to relieve symptoms such as dryness and itching associated with eczema[1][3][5][7].

Brand names
AVEENO DermexaAVEENO Dermexa Daily Emollient CreamAVEENO Dermexa Soothing Emollient Cream
Other names
Aveeno Baby Dermexa Moisturizing Cream
02

Targets

Stratum corneum lipids

Beyond the preview

Go deeper on AVEENO Dermexa.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AVEENO Dermexa.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call